Anzeige
Mehr »
Mittwoch, 24.06.2026 - Börsentäglich über 12.000 News
Schuldenfrei, 1,5 Mio. Unzen Gold und Produktion ab 2027: Vor dem Ausbruch?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 907048 | ISIN: FR0000035370 | Ticker-Symbol: 1DJ
Stuttgart
23.06.26 | 21:57
22,450 Euro
-1,32 % -0,300
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
BASTIDE LE CONFORT MEDICAL SA Chart 1 Jahr
5-Tage-Chart
BASTIDE LE CONFORT MEDICAL SA 5-Tage-Chart
RealtimeGeldBriefZeit
22,40023,70023.06.

Aktuelle News zur BASTIDE LE CONFORT MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
01.06.BASTIDE: Completion of the disposal of New Medical Concept, the holding company of EXPERF Group, to Sapio Group338Caissargues, 1st June 2026 - Bastide Group announces the completion of the acquisition by Sapio Group of its subsidiary New Medical Concept, the holding company of the French EXPERF Group, a specialist...
► Artikel lesen
21.05.BASTIDE: Groupe Bastide sells New Medical Concept, the holding company of EXPERF group - Erratum452Caissargues, 21 May 2026 -Groupe Bastide today announced the signing of an agreement for the disposal of its subsidiary New Medical Concept, the holding company of the French group EXPERF, specialized...
► Artikel lesen
BASTIDE LE CONFORT MEDICAL Aktie jetzt für 0€ handeln
21.05.BASTIDE: Groupe Bastide sells New Medical Concept, the holding company of EXPERF group399Caissargues, 21 May 2026 -Groupe Bastide today announced the signing of an agreement for the disposal of its subsidiary New Medical Concept, the holding company of the French group EXPERF, specialized...
► Artikel lesen
13.05.BASTIDE: Strong momentum for the first nine months of the financial year: up 7.2% on an organic basis686Sustained growth in home healthcare services: up 8.5% Solid growth of 5.2% in Homecare, including the one-off impact of the VPH* reform in the third quarter 2025-2026 targets confirmed Caissargues...
► Artikel lesen
18.03.BASTIDE: 2025-2026 half-year results1.019Recurring operating margin: 9.0%, in line with the annual target Operating profit up 12.5% Operating free cash flow: €24.3 million, a threefold increase in one year Significant improvement...
► Artikel lesen
12.02.BASTIDE: Organic growth of 8.2% in first-half 2025-2026: Confirmed excellent growth momentum in home healthcare services: 9.2% / Accelerated growth in the Homecare business, up 6.5% // 2025-2026 targets confirmed475Caissargues, February 12, 2026 - Groupe Bastide, a leading European provider of home healthcare services, has published its revenue for first-half 2025-2026, ending December 31, 2025. In...
► Artikel lesen
13.11.25BASTIDE: Organic growth of 8.3% in first-quarter 2025-2026: Sustained growth in home healthcare services, up 10.7% / Homecare business up 4.7%, driven by the healthcare institutions business (up 8.5%)534Caissargues, November 13, 2025 - Groupe Bastide, a leading European provider of home healthcare services, has published its revenue for first-quarter 2025-2026, ending September 30, 2025. In...
► Artikel lesen
28.10.25BASTIDE: 2025-2026 financial calendar1.061Caissargues, October 28, 2025 Events Dates* 2025-2026 Q1 Revenue Thursday November 13, 2025 2025-2026 H1 Revenue Thursday February 12, 2026 2025-2026 H1 Results Wednesday...
► Artikel lesen
22.10.25BASTIDE: 2024-2025 annual results in line with targets // 2025-26 outlook: Revenue of over EUR 510 million and recurring operating margin around 9%, Leverage of less than 3x and decrease in financial expenses943Caissargues, October 22, 2025 - Groupe Bastide, a leading European provider of home healthcare services, has announced its 2024-2025 annual results at June 30, 2025. The 2024-2025 annual consolidated...
► Artikel lesen
24.09.25BASTIDE: Groupe Bastide completes the sale of Baywater Healthcare to Sapio Group843Caissargues, September 24, 2025 In line with the timetable set out in its 30 June 2025 communication announcing the agreement to sell Baywater Healthcare, a leading player in the UK respiratory...
► Artikel lesen
04.09.25BASTIDE: 2024-2025 revenue target met // 2024-2025 revenue from continuing operations: EUR 491 million, up 8% ( EUR 561 million, excluding impact of disposals)613Caissargues, September 4, 2025 Groupe Bastide has published its annual revenue for 2024-2025. In accordance with IFRS 5, reported revenue relates exclusively to continuing operations, and no...
► Artikel lesen
30.06.25BASTIDE: Bastide Groupe Sells Baywater Healthcare To Sapio Group787Crewe, United Kingdom & Monza, Italy - 30th June 2025 Bastide le Confort Medical SA (hereinafter "Groupe Bastide") today announced that it has agreed to the sale of its subsidiary Baywater Healthcare...
► Artikel lesen
12 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1